These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
153 related items for PubMed ID: 38110341
1. Denosumab for an inoperable giant cell tumour of the ischial bone. Paul AG, See LP, Ohn MH, Ohn KM. BMJ Case Rep; 2023 Dec 18; 16(12):. PubMed ID: 38110341 [Abstract] [Full Text] [Related]
2. Giant cell tumour of bone in the denosumab era. van der Heijden L, Dijkstra PDS, Blay JY, Gelderblom H. Eur J Cancer; 2017 May 18; 77():75-83. PubMed ID: 28365529 [Abstract] [Full Text] [Related]
3. [Denosumab may be a supplement to the surgical treatment of giant cell tumours of bone]. Sørensen AL, Hansen RL, Jørgensen PH. Ugeskr Laeger; 2016 Sep 05; 178(36):. PubMed ID: 27593237 [Abstract] [Full Text] [Related]
4. Recurrent giant cell tumour of the thoracic spine managed by total en bloc spondylectomy and denosumab therapy: a case report. Duan PG, Sheng YH, Deng CH, Tang BY, Yao HQ. BMC Musculoskelet Disord; 2020 Feb 15; 21(1):105. PubMed ID: 32061254 [Abstract] [Full Text] [Related]
5. Successful total en bloc spondylectomy of the L3 vertebra with a paravertebral giant cell tumor following preoperative treatment with denosumab: a case report. Kinoshita H, Orita S, Yonemoto T, Ishii T, Iwata S, Kamoda H, Tsukanishi T, Inage K, Abe K, Inoue M, Norimoto M, Umimura T, Fujimoto K, Shiga Y, Kanamoto H, Furuya T, Takahashi K, Ohtori S. J Med Case Rep; 2019 Apr 26; 13(1):116. PubMed ID: 31023361 [Abstract] [Full Text] [Related]
6. Recurrent giant cell tumour of the distal ulna after en bloc resection with preoperative denosumab use. Fujihara N, Hamada S, Yoshida M, Tsukushi S. BMJ Case Rep; 2021 Nov 11; 14(11):. PubMed ID: 34764115 [Abstract] [Full Text] [Related]
7. Denosumab in advanced/unresectable giant-cell tumour of bone (GCTB): For how long? Palmerini E, Chawla NS, Ferrari S, Sudan M, Picci P, Marchesi E, Leopardi MP, Syed I, Sankhala KK, Parthasarathy P, Mendanha WE, Pierini M, Paioli A, Chawla SP. Eur J Cancer; 2017 May 11; 76():118-124. PubMed ID: 28324746 [Abstract] [Full Text] [Related]
8. Neoadjuvant and Adjuvant Treatment with Denosumab in Aggressive Giant-cell Tumor of Bone in the Proximal Fibula: a Case Report. Marinova VV, Slavchev SA, Patrikov KD, Tsenova PM, Georgiev GP. Folia Med (Plovdiv); 2018 Dec 01; 60(4):637-640. PubMed ID: 31188771 [Abstract] [Full Text] [Related]
9. The role of Denosumab in joint preservation for patients with giant cell tumour of bone. Perrin DL, Visgauss JD, Wilson DA, Griffin AM, Abdul Razak AR, Ferguson PC, Wunder JS. Bone Joint J; 2021 Jan 01; 103-B(1):184-191. PubMed ID: 33380180 [Abstract] [Full Text] [Related]
10. Current concepts in the treatment of giant cell tumour of bone. van der Heijden L, Dijkstra S, van de Sande M, Gelderblom H. Curr Opin Oncol; 2020 Jul 01; 32(4):332-338. PubMed ID: 32541321 [Abstract] [Full Text] [Related]
11. Efficacy of denosumab in joint preservation for patients with giant cell tumour of the bone. Traub F, Singh J, Dickson BC, Leung S, Mohankumar R, Blackstein ME, Razak AR, Griffin AM, Ferguson PC, Wunder JS. Eur J Cancer; 2016 May 01; 59():1-12. PubMed ID: 26990281 [Abstract] [Full Text] [Related]
12. Current management of giant-cell tumor of bone in the denosumab era. Nagano A, Urakawa H, Tanaka K, Ozaki T. Jpn J Clin Oncol; 2022 May 05; 52(5):411-416. PubMed ID: 35199172 [Abstract] [Full Text] [Related]
13. Giant cell tumor of the thoracic spine completely removed by total spondylectomy after neoadjuvant denosumab therapy. Yonezawa N, Murakami H, Kato S, Takeuchi A, Tsuchiya H. Eur Spine J; 2017 May 05; 26(Suppl 1):236-242. PubMed ID: 28396950 [Abstract] [Full Text] [Related]
14. Early evaluation of the therapeutic effect of denosumab on tartrate-resistant acid phosphatase 5b expression in a giant cell tumor of bone: a case report. Watanabe N, Matsumoto S, Shimoji T, Ae K, Tanizawa T, Gokita T, Motoi N, Ueno T, Koizumi M. BMC Res Notes; 2014 Sep 05; 7():608. PubMed ID: 25193435 [Abstract] [Full Text] [Related]
15. Denosumab in giant cell tumour of bone in the pelvis and sacrum: Long-term therapy or bone resection? Sambri A, Medellin MR, Errani C, Campanacci L, Fujiwara T, Donati D, Parry M, Grimer R. J Orthop Sci; 2020 May 05; 25(3):513-519. PubMed ID: 31155442 [Abstract] [Full Text] [Related]
16. Morphological Transformation of Giant-Cell Tumor of Bone After Treatment with Denosumab: A Case Report. Zhang Y, Ilaslan H, Krishnaney AA, Bauer TW. JBJS Case Connect; 2016 May 05; 6(3):e74. PubMed ID: 29252651 [Abstract] [Full Text] [Related]
17. Short-term Preoperative Denosumab With Surgery in Unresectable or Recurrent Giant Cell Tumor of Bone. Zhang RZ, Ma TX, Qi DW, Zhao M, Hu T, Zhang GC. Orthop Surg; 2019 Dec 05; 11(6):1101-1108. PubMed ID: 31762217 [Abstract] [Full Text] [Related]
18. Response to Denosumab in 2 Children With Recurrent Giant Cell Tumor of the Bone With Pulmonary Metastasis. Reddy K, Ramirez L, Kukreja K, Venkatramani R. J Pediatr Hematol Oncol; 2021 Mar 01; 43(2):e215-e218. PubMed ID: 31714440 [Abstract] [Full Text] [Related]
19. Clinical, radiological and pathological outcomes following treatment of primary giant cell tumour of bone with Denosumab. Murphy B, Vodanovich D, Spelman T, Gullifer J, Slavin J, Powell G, Pang G, Choong P. ANZ J Surg; 2020 Dec 01; 90(12):2553-2558. PubMed ID: 32767541 [Abstract] [Full Text] [Related]
20. Denosumab does not decrease the risk of lung metastases from bone giant cell tumour. Tsukamoto S, Mavrogenis AF, Leone G, Righi A, Akahane M, Tanzi P, Kido A, Honoki K, Tanaka Y, Donati DM, Errani C. Int Orthop; 2019 Feb 01; 43(2):483-489. PubMed ID: 30099641 [Abstract] [Full Text] [Related] Page: [Next] [New Search]